Vision-Sciences Inc. (NASDAQ: CGNT) shares rose in value Monday Nov 14 with heavier trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.
Meanwhile as investors continued to try and decipher policy proposals of President-elect Donald Trump’s administration, the Dow Jones Industrial Average DJIA, +0.11% rose 21.03 points, or 0.1%, to finish at 18,868.69, its third straight record close. The blue-chip index had also touched a historic high of 18,934.05 during the session.
The S&P 500 index SPX, -0.01% fell 0.25 points to end at 2,164.20, and the Nasdaq Composite COMP, -0.36% dropped 18.72 points, or 0.4%, to close at 5,218.40.
Analysts at Zacks Investment Research upgraded shares of Vision-Sciences Inc. (NASDAQ: CGNT) from Hold to Strong-Buy today. With a rating of Strong-Buy on the shares, Vision-Sciences Inc. has a 52-week high of $2.48. As a means of comparison, a number of other analysts have commented on the company in recent days, and Vision-Sciences Inc. has earned a consensus one-year price target of $2.20, less than the opening price of $2.30, a difference of 9.21 percent. Stock prices often shift to the upside on recommendations and new price targets of professional analysts.
Shares of Vision-Sciences Inc. (NASDAQ: CGNT) opened at $2.30 on Monday and traded in a range between, $2.16 and $2.48, and last traded at $2.39, which is an increase of $0.17 or 7.66% from the previous closing price.
Vision-Sciences Inc. (NASDAQ: CGNT) now has a market cap of 62.48M.
Vision-Sciences Inc.Average Daily Trading Volume
607,531 shares traded hands yesterday, higher than the average, out of a total float 15,499,000. Significant expansions in trading volume and price inflation together could indicate heavy volume aggregation by institutional investors.
As with all possible breakouts, investors look for volume to be at least 40%-50% higher than normal on the breakout to indicate that fund managers and other professional investors are jumping in.
Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.
Professional investors such as these have substantial teams of analysts researching thousands of stocks, so it is good corroboration to see them buying a stock you are considering.
Vision-Sciences Inc. Moving Averages
A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.
This is because the average acts like a floor (support), so the price bounces up off of it.
In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.
By spotting trends, moving averages allow traders to make those trends work in their favor and increase the number of successful trades.
Trades for Vision-Sciences Inc. (NASDAQ: CGNT) have ranged from $0.71 – 2.48, and the stock now has a 50-day MA of $1.68 and 200-day MA of $1.26. Today’s last price is 3.63%% below the 52 week high of $2.48.
Earnings growth is a critical factor to research when buying stocks and investors watch for companies that have raised their earnings by at least 25% over the past 3 years.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.